These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34651222)

  • 1. Pharmacokinetic and pharmacodynamic assessment of histamine H
    Kimura Y; Takahata K; Shimazaki T; Kitamura S; Seki C; Ikoma Y; Ichise M; Kawamura K; Yamada M; Zhang MR; Higuchi M; Nishino I; Suhara T
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1127-1135. PubMed ID: 34651222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Potent and Selective Histamine H
    Hino N; Marumo T; Kotani M; Shimazaki T; Kaku-Fukumoto A; Hikichi H; Karasawa JI; Tomishima Y; Komiyama H; Tatsuda E; Nozawa D; Nakamura T; Chaki S
    J Pharmacol Exp Ther; 2020 Nov; 375(2):276-285. PubMed ID: 32862143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal dose determination of enerisant (TS-091) for patients with narcolepsy: two randomized, double-blind, placebo-controlled trials.
    Inoue Y; Uchiyama M; Umeuchi H; Onishi K; Ogo H; Kitajima I; Matsushita I; Nishino I; Uchimura N
    BMC Psychiatry; 2022 Feb; 22(1):141. PubMed ID: 35193545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [(11)C]TASP457, a novel PET ligand for histamine H3 receptors in human brain.
    Kimura Y; Seki C; Ikoma Y; Ichise M; Kawamura K; Takahata K; Moriguchi S; Nagashima T; Ishii T; Kitamura S; Niwa F; Endo H; Yamada M; Higuchi M; Zhang MR; Suhara T
    Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1653-63. PubMed ID: 26902370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AZD5213: a novel histamine H3 receptor antagonist permitting high daytime and low nocturnal H3 receptor occupancy, a PET study in human subjects.
    Jucaite A; Takano A; Boström E; Jostell KG; Stenkrona P; Halldin C; Segerdahl M; Nyberg S
    Int J Neuropsychopharmacol; 2013 Jul; 16(6):1231-9. PubMed ID: 23217964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (11)C-MK-8278 PET as a tool for pharmacodynamic brain occupancy of histamine 3 receptor inverse agonists.
    Van Laere KJ; Sanabria-Bohórquez SM; Mozley DP; Burns DH; Hamill TG; Van Hecken A; De Lepeleire I; Koole M; Bormans G; de Hoon J; Depré M; Cerchio K; Plalcza J; Han L; Renger J; Hargreaves RJ; Iannone R
    J Nucl Med; 2014 Jan; 55(1):65-72. PubMed ID: 24263088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring occupancy of the histamine H
    Rusjan P; Sabioni P; Di Ciano P; Mansouri E; Boileau I; Laveillé A; Capet M; Duvauchelle T; Schwartz JC; Robert P; Le Foll B
    Br J Pharmacol; 2020 Aug; 177(15):3464-3472. PubMed ID: 32293706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosynthesis and quality control of [
    Hanyu M; Kawamura K; Takei M; Furutsuka K; Shiomi S; Fujishiro T; Ogawa M; Nengaki N; Hashimoto H; Fukumura T; Zhang MR
    Nucl Med Biol; 2016 Nov; 43(11):679-684. PubMed ID: 27580212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpectedly high affinity of a novel histamine H(3) receptor antagonist, GSK239512, in vivo in human brain, determined using PET.
    Ashworth S; Berges A; Rabiner EA; Wilson AA; Comley RA; Lai RY; Boardley R; Searle G; Gunn RN; Laruelle M; Cunningham VJ
    Br J Pharmacol; 2014 Mar; 171(5):1241-9. PubMed ID: 24670146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of receptor occupancy in the presence of mass dose: [
    Gallezot JD; Planeta B; Nabulsi N; Palumbo D; Li X; Liu J; Rowinski C; Chidsey K; Labaree D; Ropchan J; Lin SF; Sawant-Basak A; McCarthy TJ; Schmidt AW; Huang Y; Carson RE
    J Cereb Blood Flow Metab; 2017 Mar; 37(3):1095-1107. PubMed ID: 27207170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-drug interaction potential and clinical pharmacokinetics of enerisant, a novel potent and selective histamine H
    Terasaka S; Hachiuma K; Mano Y; Onishi K; Kitajima I; Nishino I; Endo H
    Xenobiotica; 2021 Jul; 51(7):786-795. PubMed ID: 33910470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 11C-GSK189254 as a novel radioligand for the H3 receptor in humans using PET.
    Ashworth S; Rabiner EA; Gunn RN; Plisson C; Wilson AA; Comley RA; Lai RY; Gee AD; Laruelle M; Cunningham VJ
    J Nucl Med; 2010 Jul; 51(7):1021-9. PubMed ID: 20554726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of the Dual-Action Anti-Parkinsonian Drug AG-0029 to Dopamine D
    Ghazanfari N; van Waarde A; Doorduin J; Sijbesma JWA; Kominia M; Koelewijn M; Attia K; Vállez-García D; Willemsen ATM; Heeres A; Dierckx RAJO; Visser TJ; de Vries EFJ; Elsinga PH
    Mol Pharm; 2022 Jul; 19(7):2287-2298. PubMed ID: 35732005
    [No Abstract]   [Full Text] [Related]  

  • 14. Blockade of the brain histamine H3 receptor by JNJ-39220675: preclinical PET studies with [¹¹C]GSK189254 in anesthetized baboon.
    Logan J; Carruthers NI; Letavic MA; Sands S; Jiang X; Shea C; Muench L; Xu Y; Carter P; King P; Fowler JS
    Psychopharmacology (Berl); 2012 Oct; 223(4):447-55. PubMed ID: 22614669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging Histamine H3 Receptors with Positron Emission Tomography.
    Rusjan PM; Le Foll B
    Curr Top Behav Neurosci; 2022; 59():147-167. PubMed ID: 34964937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging histamine H3 receptors with [
    Sandiego CM; Barret O; Lee H; Alagille D; Amenta A; Fowles K; Holden D; Seibyl JP; Tamagnan G
    Synapse; 2019 Jul; 73(7):e22096. PubMed ID: 30835877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11C-GSK189254: a selective radioligand for in vivo central nervous system imaging of histamine H3 receptors by PET.
    Plisson C; Gunn RN; Cunningham VJ; Bender D; Salinas CA; Medhurst AD; Roberts JC; Laruelle M; Gee AD
    J Nucl Med; 2009 Dec; 50(12):2064-72. PubMed ID: 19910432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen.
    Tashiro M; Mochizuki H; Sakurada Y; Ishii K; Oda K; Kimura Y; Sasaki T; Ishiwata K; Yanai K
    Br J Clin Pharmacol; 2006 Jan; 61(1):16-26. PubMed ID: 16390347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the H3 receptor antagonist radioligand [3H]-A-349821 to reveal in vivo receptor occupancy of cognition enhancing H3 receptor antagonists.
    Miller TR; Milicic I; Bauch J; Du J; Surber B; Browman KE; Marsh K; Cowart M; Brioni JD; Esbenshade TA
    Br J Pharmacol; 2009 May; 157(1):139-49. PubMed ID: 19413577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography.
    Yanai K; Ryu JH; Watanabe T; Iwata R; Ido T; Sawai Y; Ito K; Itoh M
    Br J Pharmacol; 1995 Sep; 116(1):1649-55. PubMed ID: 8564232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.